Back to Search Start Over

Rôle du chaperon moléculaire de l’alpha-hémoglobine dans la formation de l’hémoglobine et l’expression clinique de certaines hémoglobinopathies

Authors :
Véronique Baudin-Creuza
C Vasseur
BAUDIN-CREUZA, Véronique
IMRB - 'Transfusion et Maladies du Globule Rouge' [Créteil] (U955 Inserm - UPEC)
Institut Mondor de Recherche Biomédicale (IMRB)
Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)
Laboratoire d'Excellence : Biogenèse et pathologies du globule rouge (Labex Gr-Ex)
Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Source :
Transfusion Clinique et Biologique, Transfusion Clinique et Biologique, Elsevier, 2015, 22 (1), pp.49-57. ⟨10.1016/j.tracli.2015.01.002⟩
Publication Year :
2015
Publisher :
Elsevier BV, 2015.

Abstract

International audience; Alpha-hemoglobin stabilizing protein (AHSP), described as a chaperone of alpha-hemoglobin (α-Hb), is synthesized at a high concentration in the erythroid precursors. AHSP specifically recognizes the G and H helices of α-Hb and forms a stable complex with free α-Hb until its association with the partner β-subunits. Unlike the free β-Hb which are soluble and form homologous tetramers, freshly synthesized α-Hb chains are highly unstable molecular species which precipitate and generate reactive oxygen species within the erythrocyte precursors of the bone marrow leading to apoptosis and ineffective erythropoiesis. AHSP protects the free α-Hb chains in maintaining it in the soluble state. In this review, we report data from the literature and our laboratory concerning the key role of AHSP in the biosynthesis of Hb and its possible involvement in some disorders of the red blood cell as well as the hemoglobinopathies and we discuss its use as a prognostic tool in thalassemia syndromes.

Details

ISSN :
12467820 and 19538022
Volume :
22
Database :
OpenAIRE
Journal :
Transfusion Clinique et Biologique
Accession number :
edsair.doi.dedup.....c3b6db36189e262c474015c83e3ad44a